Eli Lilly drug shown to slow Alzheimer’s progression
Dementia experts hail ‘watershed moment’ after trial results for donanemab antibody treatment
Full Article
Eli Lilly drug shown to slow Alzheimer’s progression
FT.com
0 shares
1 views
You might like
Related news coverage
FirstFT: ‘Watershed moment’ as Eli Lilly drug shown to slow Alzheimer’s progression
Also in today’s newsletter, Russia pulls out of Black Sea grain deal and the mysterious absence of China’s foreign minister
FT.com